Ceres Inc (CERE), Syngenta AG (ADR) (SYT): Stay Away From This Overnight Multibagger

Page 1 of 2

Shares of energy crop developer Ceres Inc (NASDAQ:CERE) surged more than 100% from the opening bell Monday to early trading on Thursday. In fact, over one-third of the total outstanding shares traded hands on Thursday. Even with the move the company is trading for “only” $100 million. With some of the biggest names in industrial biotech on its side — such as Syngenta AG (ADR) (NYSE:SYT), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Amyris Inc (NASDAQ:AMRS), Valero Energy Corporation (NYSE:VLO), Novozymes, Gruppo M&G, and Mascoma, to name a few — this must be a good buy right? Not so fast.

Syngenta AG (ADR) (NYSE:SYT)

What does Ceres do?
Ceres Inc (NASDAQ:CERE) mines and manipulates the genomes of energy crops such as sweet sorghum and switchgrass to increase drought tolerance, biomass yield, and salt tolerability. Essentially, it has a similar business model as Syngenta AG (ADR) (NYSE:SYT) and Monsanto Company (NYSE:MON), just for energy crops. Syngenta AG (ADR) (NYSE:SYT) has actually licensed Ceres Inc (NASDAQ:CERE)’ bioinformatics software since 2008 to develop its own crops. In return, Syngenta AG (ADR) (NYSE:SYT) has upgraded the capability of the computer program. Meanwhile, Monsanto Company (NYSE:MON) and Ceres Inc (NASDAQ:CERE) tangled up in 2002 to identify and develop engineered row crops such as corn and soybeans. Those payments now are a distant memory.

I was once an intern shoved into a similar chemical closet. This one houses thousands of experimental plants for Ceres. Source: Ceres

The similarities to Syngenta AG (ADR) (NYSE:SYT) and Monsanto Company (NYSE:MON) do not mean Ceres Inc (NASDAQ:CERE) is worthy of investment, though. In fact, I think it could be a dangerous trap for just that reason. This latest pop is particularly worrisome to me. So what actually happened?

Why you shouldn’t be a buyer
Did the company announce a major development? Nope, its last press release occurred on Jan. 8, 2013. Perhaps a big insider made a big purchase? Nope — its last update to the SEC occurred on April 11, 2013. So what would cause this developmental stage to climb so rapidly? I can only come up with three possible scenarios:

    1. A potential buyout: Nothing is worse than speculating about a buyout, but I suppose a bigger player could go after the 100 issued and 210 pending patents held by Ceres Inc (NASDAQ:CERE)– more than many industrial biotech companies. This is just a guess to explain the massive share movement, and every day that passes without an announcement makes this less and less likely.
    2. Momentum trades: We at The Motley Fool think technical trading is hogwash, but if that’s your game all power to you. I couldn’t tell you what shape the stock chart took leading into the run-up (a dancing dragon trail, perhaps?) — and I don’t really care. If momentum traders are piling in to try to make a quick profit, then they will be out just as quickly. Don’t be caught holding the bag.
Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!